RSNA 2017 News

FDA clears Hologic's breast density assessment software

By staff writers
November 26, 2017

Women's imaging firm Hologic has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Quantra 2.2 breast density assessment software.

The new software uses an algorithm to analyze the distribution and texture of breast tissue in mammography images, which enables physicians to provide patient-specific breast density assessments during routine breast cancer screenings.

The Quantra software is available for Hologic's 3D Mammography system, both of which are on display at this week's RSNA 2017 meeting in Chicago.

Hologic sees strong growth in Q4 revenues
Driven by the addition of sales from its acquisition of Cynosure, women's imaging firm Hologic reported a 10% increase in revenues for the company's fourth...
Hologic adds Dutch mammo supply deal
Women's imaging firm Hologic and its Netherlands' distributor Tromp Medical will supply mammography systems for the Dutch Breast Cancer Screening Program.
Hologic plans $350M private offering
Women's imaging firm Hologic is getting set to launch a private offering of $350 million in senior notes due in 2025.
Hologic launches new breast stabilization system
Women's imaging firm Hologic has launched a new breast stabilization system to be used with its Genius 3D Mammography exam.
Hologic launches new breast biopsy system in U.S.
Women's imaging firm Hologic has launched Brevera, a new breast biopsy system, in the U.S.

Copyright © 2017